Ya-Juan Shao
Overview
Explore the profile of Ya-Juan Shao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
12
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dou X, Mai Y, Sun Z, Wang Y, Shao Y, Cheng Y, et al.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao
. 2017 Nov;
39(5):593-601.
PMID: 29125099
Objective To study the single nucleotide polymorphisms (SNPs)that predict a patient's risk of grade 2-3 paclitaxel-induced peripheral sensory neuropathy (PSN) in Chinese Han populations.Methods Totally 216 patients received paclitaxel in...
2.
Cheng Y, Meng C, Shao Y, Li N, Zhou N, Yan X, et al.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao
. 2017 Sep;
39(4):562-567.
PMID: 28877836
Objective To explore the efficacy and toxicities of gemcitabine combined with S-1 in treating locally advanced and metastatic pancreatic ductal adenocarcinoma and prognostic factors. Methods We retrospectively analyzed the clinical...
3.
Guan M, Chen S, Ying H, Zhao L, Li X, Zhou J, et al.
Chin Med J (Engl)
. 2012 Oct;
125(20):3640-5.
PMID: 23075717
Background: Hepatic arterial infusion chemotherapy for liver metastases is under evaluation because of the high target dose and low general toxicity. To investigate the efficacy and safety of a Folfox4...
4.
Shao Y, Wang Y, Meng C, Wang Y
Zhongguo Yi Xue Ke Xue Yuan Xue Bao
. 2010 Sep;
32(4):394-7.
PMID: 20868596
Objective: To investigate the clinical treatment modality and prognosis of small cell lung cancer(SCLC). Method: We retrospectively analyzed the clinical data of 77 SCLC patients who were admitted to our...
5.
Ma S, Lin Y, Ying H, Shao Y, Li X, Bai C
Chin Med J (Engl)
. 2010 Feb;
123(1):29-33.
PMID: 20137571
Background: Pulmonary embolism, a potentially fatal event, occurs more frequently in cancer patients than in the general population. To offer an accurate diagnosis and effective treatment to such patients in...
6.
Sun Z, Hu Z, Ning X, Zhou J, Shao Y, Duan J, et al.
Zhonghua Zhong Liu Za Zhi
. 2010 Feb;
31(11):826-30.
PMID: 20137346
Objective: To investigate whether low molecular weight heparin (LMWH) may suppress the expression and secretion of vascular endothelial growth factor (VEGF) from tumor cells in vitro and inhibit the VEGF-induced...
7.
Zhou J, Bai C, Cheng Y, Jia N, Shao Y, Chen S
Zhongguo Yi Xue Ke Xue Yuan Xue Bao
. 2009 Jul;
31(3):358-61.
PMID: 19621525
Objective: To evaluate the efficacy and safety of irinotecan combined with xeloda (CAPIRI regimen) in patients with metastatic colorectal cancer after failure of chemotherapy with oxaliplatin. Methods: Totally 38 patients...